✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Hemp ProductsRegulatory PolicyPatient AccessTreatment ContinuityFederal Law Why This MattersFederal regulatory uncertainty around hemp-derived products...
Cotton: Change to marijuana drug classification ‘a step in the wrong direction’
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyRegulationFederal LawPatient AccessClinical Practice Why This MattersPolitical opposition to DEA reclassification proposals can significantly...
Sudden cannabis reclassification leaves Maryland industry, regulators confused
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyMedical CannabisPatient AccessRegulatoryMaryland Why This MattersRegulatory uncertainty directly impacts patient access to cannabis medicines...
U.S. Department of Justice’s move could lower tax burdens for cannabis companies
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyPatient AccessHealthcare EconomicsMedical CannabisRegulation Why This MattersTax policy changes affecting cannabis companies directly impact...
Characterizing public comments via Regulations.gov in response to proposed cannabis rescheduling in the United States.
The United States Drug Enforcement Administration’s (DEA) proposed rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances A…
DOJ reschedules medical marijuana, leaves out NY’s recreational shops – NEWS10 ABC
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyMedical CannabisFederal RegulationPatient AccessClinical Research Why This MattersDEA rescheduling of cannabis from Schedule I...
Trump administration moves to reschedule medical marijuana | WUNC News
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyMedical CannabisFda RegulationClinical ResearchPatient Access Why This MattersFederal rescheduling of cannabis would fundamentally alter...
South Florida attorney weighs in on move to ease restrictions on medical marijuana
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyMedical CannabisFloridaLegal FrameworkPatient Access Why This MattersLegal framework changes directly impact patient access to...
Medical marijuana reclassified under federal law, sparking debate over research, taxes and …
✦ New CED Clinical Relevance #88High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic PolicyResearchFederal RegulationClinical PracticePatient Access Why This MattersFederal reclassification of cannabis from Schedule I...
What to Know About Trump’s Reclassification of Medical Marijuana – Time Magazine
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyFederal RegulationClinical PracticeResearchPatient Access Why This MattersFederal reclassification could fundamentally alter the regulatory landscape...